Resources

Selected
  • Systematic reviews (SYSVAC)
Type of publications
Regions
Diseases
Vaccine topics
Target population
Publication date
3100 results found
2025 ∙ Lei, Z. J. Bai, M. X. Li, M. J. Jin, P. Ding, Y. B.
The Effectiveness and Influence of COVID-19 Vaccination on Perinatal Individuals and Their Newborns: An Updated Meta-Analysis
Pregnant women COVID-19 Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Mousavi, S. M. Younesian, S. Yunesian, M. Fotouhi, A.
The efficacy and effectiveness of COVID-19 vaccines in Iran: a systematic review and meta-analysis
Eastern Mediterranean Islamic Republic of Iran All age groups COVID-19 Efficacy/effectiveness Administration
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Yan, X. Liu, Y. Chen, F. Chang, Z. Zhang, Z. Pons-Salort, M. Grassly, N. C.
The efficacy and effectiveness of enterovirus A71 vaccines against hand, foot, and mouth disease: A systematic review and meta-analysis
Western Pacific China Newborn Children Efficacy/effectiveness Administration
Methodological quality (AMSTAR 2):
Low
2025 ∙ Shahrebabak, A. G. Rezaei, M. Shahpar, A. Nezhad, N. Z. Sarasyabi, M. S. Nakhaie, M. Shahrebabak, M. G. Bahri, R. A.
The efficacy of COVID-19 vaccination in cystic fibrosis patients: a systematic review
Adolescents Adults Older adults COVID-19 Safety Efficacy/effectiveness Administration
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Zarekar, M. Al-Shehabi, H. Dorner, R. Weishaar, H. Lennemann, T. El Bcheraoui, C. Bernasconi, A.
The impact of information and communication technology on immunisation and immunisation programmes in low-income and middle-income countries: a systematic review and meta-analysis
Children Low and Middle Income Countries Coverage Logistics
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Clarke, M. McMillan, M. Giles, L. C. Riley, K. Andraweera, P. Richmond, P. C. Mathew, S. M. Marshall, H. S.
The impact of obesity on influenza Vaccine immunogenicity: A systematic review
All age groups Pregnant women Healthcare workers Influenza Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Low
2025 ∙ Lee, H. Cho, J. Y. Vietri, J. Dawson, E. Chaiyakunapruk, N.
The incremental net monetary benefit of higher-valent pneumococcal conjugate vaccines for adults: a systematic review and meta-analysis of economic evaluations
Adults Older adults Pneumococcal disease Economic aspects Administration
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Palotino-Ferreira, B. M. Rocha, S. V. Nunes-Silva, A. Souza-Gomes, A. F. Rodrigues, F. Coelho, P. Bachi, A. L. L. de Oliveira, R. A. de Barros, M. P. Furtado, G. E.
The influence of structured physical activity on vaccination response from adults to older individuals: a systematic review on the Immunoinflammatory crosstalk of COVID-19
Adults Older adults COVID-19 Efficacy/effectiveness Administration
Methodological quality (AMSTAR 2):
Low
2025 ∙ de Almeida Santos, G. de Albuquerque Luna, E. J.
The influence of the COVID-19 pandemic on measles vaccination coverage
Newborn Children Adolescents Measles Coverage Administration
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Wu, W. Liu, J. Guo, S. Zhao, H. Yang, X.
The protective efficacy of inactivated vaccine against hemorrhagic fever with renal syndrome A meta-analysis
All age groups Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
Loading...